Skip to content
ai company
Data quality: Editorially Reviewed
Boston

PathAI

PathAI develops AI-powered pathology tools, including the AISight digital pathology platform, for drug development and clinical laboratory workflows.

Visit website

About

PathAI applies artificial intelligence to histopathology for biopharma and laboratories. Its AISight cloud-native platform manages pathology images, and AISight Dx is described as FDA-cleared for primary diagnosis. The company also offers algorithm products such as AIM-MASH, AIM-PDL1 and PathAssist, plus research platforms including PathExplore and IHCExplore. It states that 90 percent of the top 15 biopharma companies use its technology, and cites partners such as Labcorp and MedStar Health.

Organization type
ai company
Headquarters region
Boston
Founded
Not stated
Listings in the graph
0
Last updated
6 October 2026
Published
6 October 2026

In the graph

Loading connections…
Open the full ecosystem graph

Data sources & provenance

Where this information came from, how it was checked and when it was last looked at. “Last updated” records a change to the record — it does not mean the record was verified.

Data quality
Data quality: Editorially Reviewed
Primary source
pathai.com
Sources cited
2
Last reviewed
6 October 2026
Last updated
6 October 2026

Spotted something out of date?

Anyone can suggest a correction — you don't need an account. An editor checks every suggestion against the sources before the record changes.

Products & technologies

No published products from this organization yet.

Services

No published services from this organization yet.

News & insights from this region

No related coverage published yet.

Learning resources

No learning resources from this provider yet.

Is this your organization?

Claim this profile to keep the description, products and services accurate, or add an organization that is missing from the graph.